Jane Huang
CMO, Hematology, BeOne Medicines Ltd.
Companies
- Prelude Therapeutics IncPresident Apr 6, 2022 to now1
- Proteon TherapeuticsBoard member Jun 10, 2021 to now2
- BeOne Medicines Ltd.CMO, Hematology Sep 7, 2016 to Dec 16, 20213
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- BeOne Medicines Ltd. ONC160,055 shares4$59.5M at $371.86Dec 16, 2021
- Prelude Therapeutics Inc PRLD86,917 shares5$292.9K at $3.37Oct 4, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 4, 2025Shares withheld for tax 3,355 shares at $1.47 of Prelude Therapeutics Inc5
- Oct 4, 2025Exercised options 9,375 shares of Prelude Therapeutics Inc5
- Jul 4, 2025Shares withheld for tax 3,355 shares at $0.79 of Prelude Therapeutics Inc6
- Jul 4, 2025Exercised options 9,375 shares of Prelude Therapeutics Inc6
- Apr 4, 2025Shares withheld for tax 3,355 shares at $0.68 of Prelude Therapeutics Inc7
- Apr 4, 2025Exercised options 9,375 shares of Prelude Therapeutics Inc7
- Jan 4, 2025Shares withheld for tax 3,859 shares at $1.39 of Prelude Therapeutics Inc8
- Jan 4, 2025Exercised options 9,375 shares of Prelude Therapeutics Inc8
- Oct 4, 2024Shares withheld for tax 3,349 shares at $2.00 of Prelude Therapeutics Inc9
- Oct 4, 2024Exercised options 9,375 shares of Prelude Therapeutics Inc9
- Jul 4, 2024Shares withheld for tax 3,347 shares at $3.60 of Prelude Therapeutics Inc10
- Jul 4, 2024Exercised options 9,375 shares of Prelude Therapeutics Inc10
- Apr 4, 2024Shares withheld for tax 3,347 shares at $4.74 of Prelude Therapeutics Inc11
- Apr 4, 2024Exercised options 9,375 shares of Prelude Therapeutics Inc11
- Jan 4, 2024Shares withheld for tax 3,844 shares at $3.77 of Prelude Therapeutics Inc12
- Jan 4, 2024Exercised options 9,375 shares of Prelude Therapeutics Inc12
- Oct 4, 2023Exercised options 9,375 shares of Prelude Therapeutics Inc13
- Jul 4, 2023Shares withheld for tax 3,242 shares at $4.65 of Prelude Therapeutics Inc14
- Jul 4, 2023Exercised options 9,375 shares of Prelude Therapeutics Inc14
- Apr 6, 2023Sold 13,280 shares at $6.12 of Prelude Therapeutics Inc15
- Apr 4, 2023Exercised options 37,500 shares of Prelude Therapeutics Inc15
- Dec 14, 2021Sold 100 shares at $284.52 of BeOne Medicines Ltd.4
- Dec 14, 2021Sold 200 shares at $281.64 of BeOne Medicines Ltd.4
- Dec 14, 2021Sold 100 shares at $278.79 of BeOne Medicines Ltd.4
- Dec 14, 2021Sold 500 shares at $278.21 of BeOne Medicines Ltd.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARPrelude Therapeutics Inc, President
- 2SEC EDGARProteon Therapeutics, Board member
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Jul 8, 2025
- 7SEC EDGARForm 4 filed Apr 7, 2025
- 8SEC EDGARForm 4 filed Jan 7, 2025
- 9SEC EDGARForm 4 filed Oct 7, 2024
- 10SEC EDGARForm 4 filed Jul 8, 2024
- 11SEC EDGARForm 4 filed Apr 8, 2024
- 12SEC EDGARForm 4 filed Jan 8, 2024
- 13SEC EDGARForm 4 filed Oct 6, 2023
- 14SEC EDGARForm 4 filed Jul 6, 2023
- 15SEC EDGARForm 4 filed Apr 6, 2023